MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2019 International Congress

    Combination Antiretroviral therapy (cART)-induced cerebellar and prefrontal cortex disorders: A Study on the impact of Naringenin and Quercetin

    E. Akang, O. Dosumu, A. Fagaroye, I. Usman, A. Oremosu, A. Akanmu (Lagos, Nigeria)

    Objective: This study was designed to investigate the therapeutic potential of selected bioflavonoids on cART-induced neurological disorders. Background: Long term usage of combination antiretroviral therapy…
  • 2019 International Congress

    Identification of genetic alterations and SNCA mutation in Parkinson’s disease patients of Coimbatore Population, India

    D. Venkatesan, B. Vellingiri (Coimbatore, India)

    Objective: The aim of the study is to analyze the genetic alterations in SNCA gene and dopamine transporter in 22 PD patients of Coimbatore population.…
  • 2019 International Congress

    The dopamine receptor antagonist haloperidol enhances beta and gamma oscillations and bursts in the motor cortex

    M. Alam, T. Doll, J. Krauss, K. Schwabe (Hannover, Germany)

    Objective: We aimed to investigate the changes in oscillatory activity in the motor cortex (MCtx) and the sensorimotor cortex (SMCtx) of rats after acute injection…
  • 2019 International Congress

    Restless Leg Syndrome In Men: Examination Of Early Non-Motor Clinical Signs Of Parkinson’s Disease

    M. şenol, M. Karaoğlan, H. Tekeli (Istanbul, Turkey)

    Objective: Restless Legs Syndrome (RLS) is a disorder characterized by an abnormal sensation, some sort of dysesthesia, which cannot be described especially on the limbs.…
  • 2019 International Congress

    Brain neurotransmitters and neuropeptides alternations in Parkinson’s induced mouse models

    N. Kumar, R. Khanna (Jaipur, India)

    Objective: Present study aimed to investigate the changes in brain neurotransmitters and neuropetides in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models  of PD. Background: Parkinson’s disease (PD), a…
  • 2019 International Congress

    Decreased serum alpha-synuclein in patients with Restless Legs Syndrome and association with SNCA-Rep1 polymorphism

    YC. Wu, XY. Zhu, TT. Wu, T. Liu, HM. Wang, YJ. Chen, X. Li, XX. Cui (Shanghai, China)

    Objective: To investigate whether α -synuclein levels are altered in serum and saliva in patients with RLS and explore influence of the SNCA-Rep1 microsatellite repeat…
  • 2019 International Congress

    Quercetin administration abrogates the Parkinson’s disease (PD)-like motor and non-motor symptoms and attenuates the behavioral, neurochemical and biochemical deficits induced by rotenone toxicity in rats

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: The present study was carried out to investigate the preventive and therapeutic effects of quercetin (a flavonol) against rotenone-induced neurotoxicity. Background: Rotenone (pesticide) induced…
  • 2019 International Congress

    Movement Disorders in Post Stroke Patients: A Retrospective Analysis

    M. Christie, V. Laticevschi, R. Mehanna (Houston, TX, USA)

    Objective: To review the prevalence of various movement disorders in post stroke patients at a tertiary, academic center and to characterize the therapeutic response to…
  • 2019 International Congress

    How Parkinson’s Disease Affects Value-Based Decisions

    L. Montaser-Kouhsari, R. Gerraty, A. Bakkour, D. Shohamy (New York, NY, USA)

    Objective: Parkinson’s Disease (PD) is a degenerative motor disease that causes subtle deficits in decision-making as a result of striatal dysfunction due to dopamine depletion.…
  • 2019 International Congress

    Enhancing the Proteasomal Degradation of Alpha Synuclein: “The Hallmark” to attenuating the Progression of Parkinson’s Disease

    B. Adebisi, M. Adeleke (Osogbo, Nigeria)

    Objective: The research aimed at preventing the accumulation of Alpha Synuclein in order to prevent it's accumulation.  It is imperative that we also establish that…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley